T1	Participants 118 194	Patients with chronic kidney disease, including kidney transplant recipients
T2	Participants 722 846	Participants are clinically stable renal transplant recipients who are 6 months or longer posttransplant with elevated tHcy.
T3	Participants 1380 1466	From August 2002 through December 2004, 2234 of the target 4000 patients were enrolled
T4	Participants 1468 1676	In accordance with trial design, mean (SD) screening tHcy was elevated (17.4 +/- 6.2 micromol/L), and mean (SD) estimated creatinine clearance was consistent with stable renal function (58.0 +/- 18.6 mL/min).
T5	Participants 1954 1981	renal transplant recipients
